Doxil® — The first FDA-approved nano-drug: Lessons learned

Barenholz, Yechezkel (Chezy)·2012·Journal of Controlled Release

Cited by (1,008)

Items 601–700 of 1,008

  1. Ultrasound-Mediated Gene and Drug Delivery Using a Microbubble-Liposome Particle System
    Young Il Yoon, Yong‐Su Kwon, Hee-Sang Cho, Sun‐Hee Heo, Kyeong Soon Park, Sang Gyu Park, Soo-Hong Lee, Sung Il Hwang, Young Il Kim, Hwan Jun Jae et al. · 2014 · Theranostics
  2. Nanomedicines - Tiny particles and big challenges
    Margareth R. C. Marques, Qiuyi Choo, Mukul Ashtikar, Thais Correa Rocha, Susanne Bremer‐Hoffmann, Matthias Gerhard Wacker · 2019 · Advanced Drug Delivery Reviews
  3. When liposomes met antibodies: Drug delivery and beyond
    Jiaxing Di, Fang Xie, Yuhong Xu · 2020 · Advanced Drug Delivery Reviews
  4. A brief history of long circulating nanoparticles
    Hajira Haroon, Alan Christy Hunter, Z. Shadi Farhangrazi, Seyed Moein Moghimi · 2022 · Advanced Drug Delivery Reviews
  5. Recent advances in using liposomes for delivery of nucleic acid-based therapeutics
    Hamdi Nsairat, Walhan Alshaer, Fadwa Odeh, Ezaldeen Esawi, Dima Khater, Abeer Al Bawab, Mohamed El‐Tanani, Abdalla Awidi, Mohammad Suleiman Mubarak · 2023 · OpenNano
  6. Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications
    Dongdong Xu, Yang Li, Shouchun Yin, Feihe Huang · 2024 · Chemical Society Reviews
  7. Polyethylene glycol immunogenicity in nanomedicine
    Yunching Chen, Yu-Cheng Su, Steve R. Roffler · 2025 · Nature Reviews Bioengineering
  8. Crosslinked multilamellar liposomes for controlled delivery of anticancer drugs
    Kye‐Il Joo, Xiao Liang, Shuanglong Liu, Yarong Liu, Chi-Lin Lee, Peter S. Conti, Michael K.K. Wong, Zibo Li, Pin Wang · 2013 · Biomaterials
  9. Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery
    Cong‐Fei Xu, Houbing Zhang, Chunyang Sun, Yang Liu, Song Shen, Xianzhu Yang, Yanhua Zhu, Jun Wang · 2016 · Biomaterials
  10. A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: From liposomal preparation to therapy
    Hamidreza Farzaneh, Maryam Ebrahimi Nik, Mohammad Mashreghi, Zahra Saberi, Mahmoud Reza Jaafari, Manouchehr Teymouri · 2018 · International Journal of Pharmaceutics
  11. Nanoparticles for biomedical applications: exploring and exploiting molecular interactions at the nano-bio interface
    Karin Nienhaus, Haixia Wang, Gerd Ulrich Nienhaus · 2020 · Materials Today Advances
  12. Extracellular vesicles for tumor targeting delivery based on five features principle
    Tuying Yong, Dongdong Wang, Xin Li, Yuchen Yan, Jun Hu, Lu Gan, Xiangliang Yang · 2020 · Journal of Controlled Release
  13. DNA Nanostructures and DNA‐Functionalized Nanoparticles for Cancer Theranostics
    Fay Nicolson, Akbar Ali, Moritz F. Kircher, Suchetan Pal · 2020 · Advanced Science
  14. Research progress in membrane fusion-based hybrid exosomes for drug delivery systems
    Anqi Liu, Gang Yang, Yuehua Liu, Tingjiao Liu · 2022 · Frontiers in Bioengineering and Biotechnology
  15. Nanoparticles for drug delivery: Insight into in vitro and in vivo drug release from nanomedicines
    Ugochi E. Ewii, Anthony Amaechi Attama, Emmanuel Oluwatoyin Olorunsola, Adaeze Linda Onugwu, Fortune Uchechukwu Nwakpa, Chioma K. Anyiam, Chinonye Chijioke, Toochukwu Ekwutosi Ogbulie · 2025 · Nano TransMed
  16. Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona
    Caracciolo, Giulio · 2018 · Nanoscale
  17. Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies
    Jolanda Spadavecchia, Dania Movia, Caroline Moore, Ciarán Manus Maguire, Hanane Moustaoui, Sandra Casale, Yuri Volkov, Adriele Prina‐Mello · 2016 · International Journal of Nanomedicine
  18. Overview on experimental models of interactions between nanoparticles and the immune system
    Saeedeh Najafi-Hajivar, Parvin Zakeri‐Milani, Hamed Mohammadi, Mehri Niazi, Mehdi Soleymani-Goloujeh, Behzad Baradaran, Hadi Valizadeh · 2016 · Biomedicine & Pharmacotherapy
  19. Theranostic Nanoparticles for Tracking and Monitoring Disease State
    Cristina L. Zavaleta, Dean Ho, Eun Ji Chung · 2017 · SLAS TECHNOLOGY
  20. Lyophilization of Nanoparticles, Does It Really Work? Overview of the Current Status and Challenges
    Matthew S. Gatto, Wided Najahi‐Missaoui · 2023 · International Journal of Molecular Sciences
  21. Breakthrough discoveries in drug delivery technologies: The next 30 years
    Davide Brambilla, Paola Luciani, Jean‐Christophe Leroux · 2014 · Journal of Controlled Release
  22. Nanomedicines for kidney diseases
    Ryan M. Williams, Edgar A. Jaimes, Daniel A. Heller · 2016 · Kidney International
  23. Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective
    Deepak Solomon, Nilesh Gupta, Nihal S. Mulla, Snehal K. Shukla, Yadir A. Guerrero, Vivek Gupta · 2017 · The AAPS Journal
  24. Drug Delivery in Cancer Therapy, Quo Vadis?
    Zheng‐Rong Lu, Peter L. Qiao · 2018 · Molecular Pharmaceutics
  25. Magnetic Targeting and Ultrasound Activation of Liposome–Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies
    Pankaj Dwivedi, Sonia Kiran, Shuya Han, Monika Dwivedi, Renuka Khatik, Rong Fan, Farhana Akbar Mangrio, Kun Du, Zhiqiang Zhu, Chaoyu Yang et al. · 2020 · ACS Applied Materials & Interfaces
  26. LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy
    Nicola d’Avanzo, Giulia Torrieri, Patrícia Figueiredo, Christian Celia, Donatella Paolino, Alexandra Correia, Karina Moslova, Tambet Teesalu, Massimo Fresta, Hélder A. Santos · 2021 · International Journal of Pharmaceutics
  27. Nanomedicines and nanomaterials for cancer therapy: Progress, challenge and perspectives
    Ziwei Jing, Qiuzheng Du, Xiaojian Zhang, Yu Zhang · 2022 · Chemical Engineering Journal
  28. Overcoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery
    Xiaohui Wang, Hong Zhang, Xiaohui Chen, Chunrong Wu, Ke Ding, Guiyin Sun, Yang Luo, Debing Xiang · 2023 · Acta Biomaterialia
  29. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis
    Chaw Yee Beh, Ray Putra Prajnamitra, Li-Lun Chen, Patrick C.H. Hsieh · 2021 · Molecules
  30. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior
    Yan Li, Ruiyuan Liu, Jun Yang, Yuanjie Shi, Guanghui Ma, Zhenzhong Zhang, Xin Zhang · 2014 · Biomaterials
  31. A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona
    Marilena Hadjidemetriou, Zahraa S. Al-Ahmady, Maurizio Buggio, Joe Swift, Kostas Kostarelos · 2018 · Biomaterials
  32. Physical properties of nanoparticles do matter
    Tony Mutiso Kiio, Soyeun Park · 2020 · Journal of Pharmaceutical Investigation
  33. Delivering more for less: nanosized, minimal-carrier and pharmacoactive drug delivery systems
    Emma L. Etter, Kuo‐Ching Mei, Juliane Nguyen · 2021 · Advanced Drug Delivery Reviews
  34. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers
    Patrick M. Glassman, Elizabeth D. Hood, Laura T. Ferguson, Zongmin Zhao, Don L. Siegel, Samir Mitragotri, Jacob Samuel Brenner, Vladimir R. Muzykantov · 2021 · Advanced Drug Delivery Reviews
  35. Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas
    Mohamadreza Amin, Ali Badiee, Mahmoud Reza Jaafari · 2013 · International Journal of Pharmaceutics
  36. Liposome-Cross-Linked Hybrid Hydrogels for Glutathione-Triggered Delivery of Multiple Cargo Molecules
    Yingkai Liang, Kristi Lynn Kiick · 2016 · Biomacromolecules
  37. PASylation®: A versatile technology to extend drug delivery
    Uli Binder, Arne Skerra · 2017 · Current Opinion in Colloid & Interface Science
  38. Formation of a protein corona influences the biological identity of nanomaterials
    Daniel Nierenberg, Annette R. Khaled, Orielyz Flores · 2018 · Reports of Practical Oncology & Radiotherapy
  39. Enhanced drug delivery using sonoactivatable liposomes with membrane-embedded porphyrins
    Xiaobing Wang, Fei Yan, Xiufang Liu, Pan Wang, Shuai Shao, Yue Ling Sun, Zonghai Sheng, Quanhong Liu, Jonathan F. Lovell, Hairong Zheng · 2018 · Journal of Controlled Release
  40. Nanoscale drug delivery systems for controllable drug behaviors by multi-stage barrier penetration
    Jinjin Wang, Qiankun Ni, Yufei Wang, Yuxuan Zhang, Hongyu He, Dawei Gao, Xiaowei Ma, Xing‐Jie Liang · 2020 · Journal of Controlled Release
  41. Nanoparticles in pregnancy: the next frontier in reproductive therapeutics
    Natasha Pritchard, Tu’uhevaha J. Kaitu’u‐Lino, Lynda K. Harris, Stephen Tong, Natalie J. Hannan · 2020 · Human Reproduction Update
  42. Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy
    Basanti Brar, Koushlesh Ranjan, Ankur Palria, Rajesh Kumar, Mayukh Ghosh, Sweety Sihag, Prasad Minakshi · 2021 · Frontiers in Nanotechnology
  43. Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
    Man Wang, Fei Yu, Yuan Zhang · 2025 · Molecular Cancer
  44. Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer
    Füredi, András, Szebényi, Kornélia, Tóth, Szilárd, Cserepes, Mihály, Hámori, Lilla, Nagy, Veronika, Karai, Edina, Vajdovich, Péter, Imre, Tímea, Szabó, Pál et al. · 2017 · Journal of Controlled Release
  45. The Potential of Stimuli-Responsive Nanogels in Drug and Active Molecule Delivery for Targeted Therapy
    Marta Vicario‐de‐la‐Torre, Jacqueline Forcada · 2017 · Gels
  46. Ultrasound responsive mesoporous silica nanoparticles for biomedical applications
    Miguel Manzano, María Vallet‐Regí · 2019 · Chemical Communications
  47. Polymeric Nanoparticles for the Treatment of Malignant Gliomas
    Basant Salah Mahmoud, Ali H. Alamri, Christopher McConville · 2020 · Cancers
  48. Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
    Marina Santiago Franco, Eliza Rocha Gomes, Marjorie Coimbra Roque, Mônica Cristina Oliveira · 2021 · Frontiers in Oncology
  49. Recent Advances in Nanoparticle-Based Cancer Treatment: A Review
    Sushant Bajpai, Saurabh Kr Tiwary, Muskan Sonker, Ayush Joshi, Vishwas Gupta, Yogendra Kumar, Nehil Shreyash, Susham Biswas · 2021 · ACS Applied Nano Materials
  50. Progress and challenges in the translation of cancer nanomedicines
    Fan Tong, Yufan Wang, Huile Gao · 2023 · Current Opinion in Biotechnology
  51. Nanoparticle-Mediated Drug Delivery Systems for Precision Targeting in Oncology
    Kamelia Hristova‐Panusheva, Charilaos Xenodochidis, Milena Georgieva, Natalia A. Krasteva · 2024 · Pharmaceuticals
  52. Antibody–drug conjugates in cancer therapy: current landscape, challenges, and future directions
    Bonan Chen, Xiaohong Zheng, Jialin Wu, Guoming Chen, Jun Qing Yu, Yi Xin Xu, William Ka Kei Wu, Gary Man-Kit Tse, Ka Fai To, Wei Kang · 2025 · Molecular Cancer
  53. Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells
    Rahul Nahire, Manas K. Haldar, Shirshendu Paul, Avinash H. Ambre, Varsha Meghnani, Buddhadev Layek, Kalpana S. Katti, Kara N. Gange, Jagdish Singh, Kausik Sarkar et al. · 2014 · Biomaterials
  54. Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials
    Henry A. Havel · 2016 · The AAPS Journal
  55. Multifunctional Click Hyaluronic Acid Nanogels for Targeted Protein Delivery and Effective Cancer Treatment in Vivo
    Jing Chen, Yan Zou, Chao Deng, Fenghua Meng, Jian Zhang, Zhiyuan Zhong · 2016 · Chemistry of Materials
  56. Programmed Multiresponsive Vesicles for Enhanced Tumor Penetration and Combination Therapy of Triple‐Negative Breast Cancer
    Fangyuan Zhou, Bing Feng, Tingting Wang, Dangge Wang, Qingshuo Meng, Jianfeng Zeng, Zhiwen Zhang, Siling Wang, Haijun Yu, Yaping Li · 2017 · Advanced Functional Materials
  57. Controlled drug release to the inner ear: Concepts, materials, mechanisms, and performance
    Karsten Mäder, Eric Lehner, Arne Liebau, Stefan K. Plontke · 2018 · Hearing Research
  58. Hyperthermia and Temperature-Sensitive Nanomaterials for Spatiotemporal Drug Delivery to Solid Tumors
    Mohamadreza Amin, Wenqiu Huang, Ann L.B. Seynhaeve, Timo L.M. ten Hagen · 2020 · Pharmaceutics
  59. Recent updates in curcumin delivery
    Mohammad A. Obeid, Manal Alsaadi, Alaa A. A. Aljabali · 2022 · Journal of Liposome Research
  60. Biomaterial‐Based In Situ Cancer Vaccines
    Bo Yang, Hua Wang · 2023 · Advanced Materials
  61. Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA–Lipid Complexes
    János Szebeni, Bálint Kiss, Tamás Bozó, Keren Turjeman, Yael Levi‐Kalisman, Yechezkel Barenholz, Miklós Kellermayer · 2023 · ACS Nano
  62. Leveraging nature’s nanocarriers: Translating insights from extracellular vesicles to biomimetic synthetic vesicles for biomedical applications
    Yunxi Chen, Noélie Douanne, T.-C. Wu, Ishman Kaur, Thupten Tsering, Armen Erzingatzian, Amélie Nadeau, David Juncker, Vahé Nerguizian, Julia Valdemarin Burnier · 2025 · Science Advances
  63. Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells
    Massimiliano Papi, Damiano D. Caputo, Valentina Palmieri, Roberto Coppola, Sara Palchetti, Francesca Bugli, Cécilia Martini, Luca Digiacomo, Daniela Pozzi, Giulio Caracciolo · 2017 · Nanoscale
  64. Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications
    Siddharth Patel, Avathamsa Athirasala, Paula dos Passos Menezes, N. Ashwanikumar, Ting Zou, Gaurav Sahay, Luiz E. Bertassoni · 2018 · Tissue Engineering Part A
  65. Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
    Keith Henry Moss, Petya G. Popova, Sine Reker Hadrup, Kira Astakhova, Maria Taskova · 2019 · Molecular Pharmaceutics
  66. Clinical Translation of Nanomedicine and Biomaterials for Cancer Immunotherapy: Progress and Perspectives
    Yang Shi · 2020 · Advanced Therapeutics
  67. Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents
    Fabio Colella, João P. Garcia, Marco Sorbona, Andrea Lolli, B.P. Antunes, Domenico D’Atri, Florian P.Y. Barré, Jacopo Oieni, Maria L. Vainieri, Luana Zerrillo et al. · 2020 · Journal of Controlled Release
  68. In vitro experiments showing enhanced release of doxorubicin from Doxil® in the presence of ammonia may explain drug release at tumor site
    Lisa Silverman, Yechezkel Barenholz · 2015 · Nanomedicine Nanotechnology Biology and Medicine
  69. Plasma Protein Adsorption and Biological Identity of Systemically Administered Nanoparticles
    Dongyu Chen, Shanthi Ganesh, Weimin Wang, Mansoor M. Amiji · 2017 · Nanomedicine
  70. Lipid composition: a “key factor” for the rational manipulation of the liposome–protein corona by liposome design
    Giulio Caracciolo, Daniela Pozzi, Anna Laura Capriotti, Chiara Cavaliere, Susy Piovesana, Heinz Wilfried Amenitsch, Aldo Laganà · 2014 · RSC Advances
  71. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems
    Merel van Elk, Bruce P. Murphy, Tatiane Eufrásio-da-Silva, Daniel P. O’Reilly, Tina Vermonden, Wim E. Hennink, Garry P. Duffy, Eduardo Ruiz‐Hernández · 2016 · International Journal of Pharmaceutics
  72. Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance
    Chuanqi Peng, Yingyu Huang, Jie Zheng · 2020 · Journal of Controlled Release
  73. Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer
    Naveen Rajana, Aare Mounika, Padakanti Sandeep Chary, Valamla Bhavana, Urati Anuradha, Dharmendra Kumar Khatri, Shashi Bala Singh, Neelesh Kumar Mehra · 2022 · Journal of Controlled Release
  74. Concepts and Approaches to Reduce or Avoid Protein Corona Formation on Nanoparticles: Challenges and Opportunities
    Matthias Barz, Wolfgang Johann Parak, Rudolf Zentel · 2024 · Advanced Science
  75. Nanoparticle-Based Modulation of the Immune System
    Ronnie H. Fang, Liangfang Zhang · 2016 · Annual Review of Chemical and Biomolecular Engineering
  76. Drug-Loaded Biocompatible Nanocarriers Embedded in Poloxamer 407 Hydrogels as Therapeutic Formulations
    Elena Giuliano, Donatella Paolino, Massimo Fresta, Donato Cosco · 2018 · Medicines
  77. Leukocyte-mimicking nanovesicles for effective doxorubicin delivery to treat breast cancer and melanoma
    Roberto Molinaro, Jonathan Otto Martinez, Assaf Zinger, Alessandro De Vita, Gianluca Storci, Noemi Arrighetti, Enrica De Rosa, Kelly A. Hartman, Nupur Basu, Nima Taghipour et al. · 2019 · Biomaterials Science
  78. Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment
    Yokoi, Kenji, Kojic, Milos, Milosevic, Miljan, Tanei, Tomonori, Ferrari, Mauro, Ziemys, Arturas · 2014 · Cancer Research
  79. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy
    Yan Zou, Ya Fang, Hao Meng, Fenghua Meng, Chao Deng, Jian Zhang, Zhiyuan Zhong · 2016 · Journal of Controlled Release
  80. Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy
    Defu Cai, Wei Gao, Bing He, Wenbing Dai, Hua Zhang, Xueqing Wang, Jiancheng Wang, Xuan Zhang, Qiang Zhang · 2013 · Biomaterials
  81. Microfluidic remote loading for rapid single-step liposomal drug preparation
    Renee R. Hood, Wyatt N. Vreeland, Don L. DeVoe · 2014 · Lab on a Chip
  82. Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update
    Xiangyu Ma, Robert O. Williams · 2017 · Journal of Pharmaceutical Investigation
  83. Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery
    Pascal Röthlisberger, Cécile Gasse, Marcel Hollenstein · 2017 · International Journal of Molecular Sciences
  84. Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin
    Hanan Abumanhal-Masarweh, Lilach Koren, Assaf Zinger, Zvi A Yaari, Nitzan Krinsky, Galoz Kaneti, Nitsan Dahan, Yael Lupu-Haber, Edith Suss-Toby, Esther Weiss‐Messer et al. · 2019 · Journal of Controlled Release
  85. Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches
    Saikat Ghosh, Ankit Javia, Saritha Rakesh Shetty, Denish Bardoliwala, Kuntal Maiti, Shubhadeep Banerjee, Ajay Jaysingh Khopade, Ambikanandan R. Misra, Krutika Khanderao Sawant, Subhas Bhowmick · 2021 · Journal of Controlled Release
  86. Lipid-Based Nanotechnology: Liposome
    Yanhao Jiang, Wenpan Li, Zhiren Wang, Jianqin Lu · 2023 · Pharmaceutics
  87. Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons
    Minhye Kim, Myeongyeon Shin, Yaping Zhao, Mrinmoy Ghosh, Young‐Ok Son · 2024 · Small Science
  88. EGCG/Gelatin-Doxorubicin Gold Nanoparticles Enhance Therapeutic efficacy of Doxorubicin for Prostate Cancer Treatment
    Li‐Chu Tsai, Hao‐Ying Hsieh, Kun-Ying Lu, Sin-Yu Wang, Fwu‐Long Mi · 2015 · Nanomedicine
  89. A Specific, Glycomimetic Langerin Ligand for Human Langerhans Cell Targeting
    Eike‐Christian Wamhoff, Jessica Schulze, Lydia Bellmann, Mareike Rentzsch, Gunnar Bachem, Felix F. Fuchsberger, Juliane Rademacher, Martin Hermann, Barbara Del Frari, Rob van Dalen et al. · 2019 · ACS Central Science
  90. Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy
    Yu‐Lin Su, Jen‐Hung Fang, Chia-Ying Liao, Chein-Ting Lin, Yun-Ting Li, Shang‐Hsiu Hu · 2015 · Theranostics
  91. Production, properties, and applications of solid self-emulsifying delivery systems (S-SEDS) in the food and pharmaceutical industries
    Antónia Gonçalves, Nooshin Nikmaram, Shahin Roohinejad, Berta N. Estevinho, Fernando A. Rocha, Ralf Greiner, David Julian McClements · 2017 · Colloids and Surfaces A Physicochemical and Engineering Aspects
  92. Nanocarriers for Vascular Delivery of Anti-Inflammatory Agents
    Melissa D. Howard, Elizabeth D. Hood, Blaine J. Zern, Vladimir V. Shuvaev, Tilo Großer, Vladimir R. Muzykantov · 2014 · The Annual Review of Pharmacology and Toxicology
  93. Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery
    Audrey Olshefsky, Christian Richardson, Suzie Hwang Pun, Neil P. King · 2022 · Bioconjugate Chemistry
  94. Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging
    Ruei‐Min Lu, Minshan Chen, De-Kuan Chang, Chien‐Yu Chiu, Wei-Chuan Lin, Shin-Long Yan, Yi‐Ping Wang, Yuan‐Sung Kuo, Chen-Yun Yeh, Albert Lo et al. · 2013 · PLoS ONE
  95. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood–brain barrier, and the transporting mechanism to glioma cells
    Chang Liu, Xiaona Liu, Guiling Wang, Yu Hei, Shuai Meng, Lingfei Yang, Lan Yuan, Ying Xie · 2017 · International Journal of Nanomedicine
  96. Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
    Dongxi Xiang, Sarah L. Shigdar, Andrew G. D. Bean, Matthew P. Bruce, Wenrong R. Yang, Motilal Mathesh, Tao Wang, Wang Yin, Phuong H.L. Tran, Hadi Al Shamaileh et al. · 2017 · Theranostics
  97. Nano-engineered delivery systems for cancer imaging and therapy: Recent advances, future direction and patent evaluation
    Ghazal Nabil, Ketki Bhise, Samaresh Sau, Mohamed Atef, Hossny A. El-Banna, Arun K. Iyer · 2018 · Drug Discovery Today
  98. TRAIL therapy and prospective developments for cancer treatment
    Bindu Thapa, Remant KC, Hasan Uludağ · 2020 · Journal of Controlled Release
  99. Factors affecting the dynamics and heterogeneity of the EPR effect: pathophysiological and pathoanatomic features, drug formulations and physicochemical factors
    Rayhanul Islam, Hiroshi Maeda, Jun Qun Fang · 2021 · Expert Opinion on Drug Delivery
  100. Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
    Yongchao Wang, Jinjin Wang, Dandan Zhu, Yufei Wang, Guangchao Qing, Yuxuan Zhang, Xiaoxuan Liu, Xing‐Jie Liang · 2021 · Acta Pharmaceutica Sinica B